How Risk Pooling Makes Precision Medicine Affordable: Lessons From China’s 110-Million-Policy Market
China’s City-Specific Commercial Health Insurance market processed over 110 million specialty drug insurance policies in the past year. We examine the risk-pooling architecture behind this scale — and what it means for Southeast Asia. …
The Cancer Insurance Gap in Southeast Asia: Why Traditional Policies Are Failing Patients
Over 70% of cancer diagnoses across Southeast Asia occur at Stage 3 or 4 — precisely when treatment is most expensive and most effective. This analysis examines why conventional insurance products fail these patients and how Cancer Precision Medicine insurance provides a structural solution. …